Serum Institute of India (SII) is the world’s largest vaccine producer in terms of volume. SII is currently workin...
In collaboration with the International Pharmaceutical Students’ Federation’s (IPSF) and the International F...
China-based Sinovac Biotech Ltd. inked a clinical development collaboration agreement with a Brazilian producer of immun...
Gernam firm BioNTech SE closed USD112.55 million debt financing agreement to support the development of the company&rsqu...
Moderna, Inc. announced on 11 June 2020 about progress on the late-stage development of mRNA-1273, the Company&rsqu...
Heat degradation of the proteins in vaccines render these expensive and precious biomedical products ineffective. Scient...
A recent Phase I clinical trial performed at the University Medical Center Hamburg-Eppendorf for a Middle East respirato...
UK-based AstraZeneca and the University of Oxford partnered on the global development and distribution ...
Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...
US based INOVIO, the International Vaccine Institute (IVI), and Seoul National University Hospital have announ...
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ) have announced that...
The Coalition for Epidemic Preparedness Innovations (CEPI) on 3 June 2020 announced a new partnering agreement to advanc...
Chikungunya is considered to be a major public health threat by the World Health Organization. A speciality vaccine...
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to creat...
US based Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...
The Netherlands-based Intravacc, one of the world's leading translational research and development vaccine ins...
Merck, known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicat...
US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...
